Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Olivier Nibourel(Inserm), Lionel Adès(Délégation Paris 7), Rami S. Komrokji(Moffitt Cancer Center), Marie Robin(Universität Hamburg), Saverio D’Amico(Humanitas University), Pierre Fenaux(Hôpital Avicenne), Caterina Gregorio(University of Trieste), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Gastone Castellani(University of Bologna), David A. Sallman, Erica Travaglino(Policlinico San Matteo Fondazione), Massimo Bernardi(Vita-Salute San Raffaele University), Luca Vago(Vita-Salute San Raffaele University), Somedeb Ball(Vanderbilt University), Manja Meggendorfer(Université Paris-Sud), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Shahram Kordasti(Guy's Hospital), Guillermo Sanz(Instituto de Salud Carlos III), Nico Gagelmann(Universität Hamburg), Carmelo Gurnari(University of Rome Tor Vergata), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Najla Al Ali(Moffitt Cancer Center), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Ulrich Germing(Heinrich Heine University Düsseldorf), Juan Carlos Caballero Berrocal(Complejo Hospitalario de Salamanca), Maria Teresa Voso(University of Rome Tor Vergata), Amer M. Zeidan(Yale Cancer Center), Lin‐Pierre Zhao, Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Giulia Rivoli(Ospedale Policlinico San Martino), Marta Spreafico(Leiden University), Francesca Ieva(Humanitas University), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jan Philipp Bewersdorf, Jaroslaw P. Maciejewski(Cleveland Clinic), Giulia Maggioni(Humanitas University), Luca Lanino(Humanitas University), Matteo Giovanni Della Porta(Humanitas University), Valeria Santini(University of Florence), Armando Santoro(IRCCS Humanitas Research Hospital), Lorenza Borin(Azienda Ospedaliera San Gerardo), Carmen Di Grazia(Ospedale Policlinico San Martino), Nicolaus Kröger, Elisabetta Sauta(Humanitas University)
Cited by 39
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k